chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the afternoon following second dose of the Pfizer Covid vaccine, I began to experience worsening of myasthenia symptoms, principally diplopia and difficulty with swallowing.  Symptoms persisted the following day and on third day following I experienced very severe fatigue in combination with diplopia, ptosis of both eyelids, right side weakness and trouble swallowing.  Called doctor, who increased prednisone and today symptoms have almost entirely abated.
brain fog; Mild Headache; swelling in hands; fever; joint pain; Extreme Fatigue/ severe fatigue; Dizziness; This is a spontaneous report received from a contactable consumer (patient). This 54-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 14:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history, no known allergies to medications, food, or other products, had not been diagnosed with COVID-19 prior to vaccination and had not received any other vaccines within 4-weeks prior to the COVID vaccine. The patient had no concomitant medications. On 30Mar2021 at 19:00 the patient experienced extreme fatigue and dizziness four hours after vaccination; six hours post-vaccination the patient experienced mild headache, swelling in hands, fever, and joint pain. The patient further reported the next day she had mild hand swelling, severe fatigue, brain fog and mild joint pain. The events were reported as non-serious and did not require hospitalization. No treatment was received for the events. The clinical outcomes of extreme fatigue, dizziness, mild headache, swelling in hands, fever, joint pain, and brain fog were recovering. It was also reported the patient had not been tested for COVID-19 since vaccination.  No follow-up attempts are needed. No further information is expected.
This case is linked with AER# 2013-06986 (same reporter). Initial report received from a healthcare professional on 14 June 2013. An 87-year-old female patient had received second dose of ADACEL, (lot number-C4313AA, expiry date-03/22/2015, route of administration was not reported) in left deltoid on 06 June 2013. The patient had no illness at time of vaccination, pre-existing physician diagnosed allergies, birth defects and medical conditions. The patient's concomitant medications were not reported. On 12 June 2013, the patient presented redness, raised and warm to toch. The patient used warm compress as corrective treatment and had not used antibiotics. The patient was advised to take BENADRYL and ADVIL (details not reported). No laboratory investigations were performed. At the time of this report, the patient was not recovered from the events. Follow up information received from a healthcare professional on 18 July 2013. The patient had received vaccine intramuscularly. Documents held by sender: none.
I have felt horrible; Every bone in my body ached except my eyebrows and eyelashes; I am so weak I have no energy; I can hardly walk; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization.  The patient medical history included autoimmune disease and "bad back", both from an unknown date and ongoing. The patient's concomitant medication included prednisone for autoimmune disease and tramadol 75 mg daily for back pain. On an unspecified date, the patient reported that: "I felt horrible, every bone in my body ached except my eyebrows and eyelashes, I am just wiped out when does this go away, I am so weak I have no energy, I can hardly walk". The patient underwent lab tests and procedures which included blood test: unknown result, on an unspecified date. The patient outcome of the events was unknown.   The information on the batch number has been requested.
Temp 102 (highest) onset next day with mini swelling at site of injection Dtap, no other sites involved.
I had the typical sore arm for a couple days after the shot and a red blotch. These faded. Then on day 8, I woke with a swollen, welted, hot red patch that felt very very very itchy. I took 1 benadryl and spoke with a nurse friend. I used a cold pack. The welts began to go down, but the raised red and very hot to the touch spot, approx 2.5 Inch diameter beside the injection site took several days to fade. If I take benadryl it helps with the itch. Also antihistamine cream on my skin. Yesterday, March 20 no issues, but today, March 21, it is itching again. My skin is hot in this spot.  When I google it looks like "covid arm"
Dyspnea, increased heart rate since vaccine  Sick visit 11/18/2021 ccovid testing, EKG, CTA, labs Sent to pulmonology- Dr. who felt was related to covid vaccine
pt recv vax 20JAN97 & 27JAN97 transferred to ER via amb-intermittent fevers, dec appetite, clear nose-sz activity lasted <5min;t102,103 R;dx w/OM L>R, ? rxn to MMR;
Aches in my leg bones, specifically the joints areas - ankles, knees. Sore back later in the evening.
Information has been received from a RN concerning a female pt who in 1988 was vaccinated with MMR II (lot # not available). Subsequently the pt experienced whole body hives. Unspecified medical attention was sought. Additional information has been requested.
Patient vomited ten minutes post-vaccination and reported feeling better immediately afterward.  6/2/21: 12:23pm - spoke to dad. Child doing fine. No questions or concerns.
DAY 1 (3/11/2021) - injection site mild soreness DAY 2 - fever of 99.2, achiness, flu-like symptoms DAY 3 - normal temperature, fatigue, sleeping 14 hours, some dizziness DAY 4 - maintaining normal temperature with mild fatigue, 2 isolation incidences of short term memory loss, some dizziness DAY 5 - maintaining normal temperature no fatigue, 3 more isolation incidences of short term memory loss
After 20 mins of being vaccinated, patient complained of little tightness in the throat and she looked anxious. She was seated and given water to sip on. After 15 mins of being monitored and from responding to the questions asked; she declared feeling better. No paramedic called.
Vaccine exposure during Pregnancy; arm soreness; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) and PAIN IN EXTREMITY (arm soreness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 30-Sep-2020 and the estimated date of delivery was 07-Jul-2021. On 08-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) and PAIN IN EXTREMITY (arm soreness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 08-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) had resolved. On 09-Jan-2021, PAIN IN EXTREMITY (arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 27-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 11:47 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 11:47 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 55.44 for dose administered on 15-Apr-2021.  No concomitant medications were reported.  Batch number 044B21A underwent temperature excursion on 15-Apr-2021 with temperature 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Left thigh red and swollen.  Cold compress and Tylenol or Ibuprofen as needed.
moderate joint pain; low fever; blurred vision.; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 04Jun2021 at 14:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced asthma and allergy to gluten. Concomitant medications included quetiapine fumarate (SEROQUEL) from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14May2021 at 13:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 09:00, the patient experienced moderate joint pain, low fever and blurred vision. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate joint pain, low fever and blurred vision was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient complains of warm and tingly sensation entire left arm, redness and swelling at sight of injection. Patient using over the counter Ibuprofen to reduce swelling and redness. Patient states happens at least once a week.
3/38/06, ax. temp 99.1; 3/29/06 at 02:30AM 105.8 Ax. Bathed and give infant Tylenol 8mg given. Temp. at 12:00 noon was 99.6. Thursday-no fever. Reported from mom, she did not seek medical treatment. Phone call from mom on 5/3/06. Reported above.
Within an hour post injection most of my joints were swollen, stiff and painful.  This lasted 24 hours.  Extreme exhaustion that continues 48 hours later. Low fever, chills, weakness, loss of appetite, brain fog continues 48 later.
shingles shot was a little rough; it was worse than the other pain; nerve pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of malaise in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID VACCINE) for covid-19 prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of malaise (received 1st dose on an unknown date, refer case US2023AMR051224).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and COVID VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced malaise (Verbatim: shingles shot was a little rough), pain (Verbatim: it was worse than the other pain) and nerve pain (Verbatim: nerve pain). Rechallenge with Shingles vaccine was positive. The outcome of the malaise and pain were unknown and the outcome of the nerve pain was not reported.   It was unknown if the reporter considered the malaise, pain and nerve pain to be related to Shingles vaccine.     It was unknown if the company considered the malaise, pain and nerve pain to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR051224   Additional Information: Receipt Date: 16-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that the second Shingles vaccine was a little rough. The patient had all the Covid shots.  The patient stated that still, from the people know who have had it, it was nothing compared to shingles.  The patient had 2 knee replacements and had a lot of nerve pain.  The patient stated that it was worse than the other pain.  The patient stated that oxy did not really touch it.  The patient stated that shingles was a nerve pain and it could go on for weeks and in some instances, be permanent.  The patient was not willing to roll that dice. The patient advised everyone to get vaccinated. As it was unclear from narrative, when patient received Covid shots, conservatively captured suspect.; Sender's Comments:  US-GSK-US2023AMR051224:Same reporter
flu like"symptoms; flu -body shakes / Tremoring would be more like chilling; tremoring with cold sensations/Tremoring would be more like chilling; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like"symptoms), TREMOR (flu -body shakes / Tremoring would be more like chilling) and CHILLS (tremoring with cold sensations/Tremoring would be more like chilling) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like"symptoms), TREMOR (flu -body shakes / Tremoring would be more like chilling) and CHILLS (tremoring with cold sensations/Tremoring would be more like chilling). At the time of the report, INFLUENZA LIKE ILLNESS (flu like"symptoms), TREMOR (flu -body shakes / Tremoring would be more like chilling) and CHILLS (tremoring with cold sensations/Tremoring would be more like chilling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  It was reported patient had the minimum compulsory required Covid-19 shots at the end of 2020.  Treatment information was not provided.
After vaccine, had fever for 3 days and sore throat with redness like strep throat. I had tightness in chest with trouble breathing regularly. This seemed to trigger the asthma symptoms which were out of the normal. I went to my doctor and was prescribed a Zpac and Advair. This seemed to help some. Before vaccine, I did not have to use Albuterol every day, just occasionally. Now, I am having to use Albuterol more frequently. I had an x-ray of my lungs and an MRI which results have not came back yet.
Patient stared feeling dizzy within minutes, his face and trunk got red. He felt he was going to faint. He was put on the floor to avoid any possible injury to the head, started sweating and shaking. After the sweating improved, he was able to sit down, and he started to throw up. Rescue was called and he was taken to the hospital. As per patient's girlfriend the same adverse event happened the first time, they had attributed it to him being on an empty stomach. His primary care physician had cleared him for his second dose four months after first dose event. Patient does have a history of fainting after getting blood work done.
This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8028, solution for injection) via an unspecified route of administration in the left arm on 11Nov2021 at 18:00 (at the age of 46-years-old) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation. Medical history included iron deficiency and had known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications received within two weeks of vaccination included FOCUS FACTOR at 2x/week, VITAMIN D3, and NUTRILITE at 2x/week, all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 17:00 (at the age of 46-years-old) as dose 1, single and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 25Apr2021 at 11:00 (at the age of 46-years-old) as a dose 2, single for COVID-19 immunisation. On 11Nov2021 at 18:00, immediately after injection, the patient had pain at injection site. On 12Nov2021 at 03:00, after 9 hours (all side effects started around the same time), the patient experienced chills, fever (38 centigrade), sweating, pain in lymph nodes (left arm pit), fatigue, nausea, muscles and joints pain, light headache, and loss of appetite. After about 80 hours almost all above side effects diminished except for sweating and lymph node pain in the left arm pit. On 14Nov2021 at 06:00, after about 60 hours, mild intermittent pain started in upper left abdomen area, which got worse about 15 minutes after each meal and improved, but did not go away after about 4 hours, which was still present at 78 hours post injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with TYLENOL 1 tablet only, which did not help at all. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain at injection site, chills, fever (38C), fatigue, nausea, muscles and joints pain, light headache, and loss of appetite was recovering. The events sweating, pain in lymph nodes, and mild intermittent pain started in upper left abdomen area was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
After the 3rd GARDASIL vaccination my daughter stopped getting her monthly menses. She had been regular up to that point. She is now suffering from depression and an eating disorder. Are there any other reported cases of girls/woman having the GARDASIL treatment and experiencing the same side effects?
As A fluke I checked my Blood pressure and it was extremely  high 191/110  only symptom was a Headache, as I would normally run 120-130 /70's-80's . I called my Dr. and  immediately and was seen  My BP was down but I question for how long was it elevated .  This was almost 7 days post Booster . I Monitored my BP for a week and it did eventually return  to normal 14 days post Vaccine.
Patient showed no signs and symptoms of adverse event after vaccination, but patient was found around 9:00pm unresponsive, no vital signs of life
Dizzness, nausea, vomiting, hands and feet swollen 3 times their size, injection site aching and swollen.
now inflammation that is causing blindness; eye irritation; inflammation; Open-Angle Glaucoma; Uveitis; Granulomatous Anterior Uveitis; Uveitic Ocular Hypertension; This is a spontaneous report from a contactable consumer (patient).   A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: er8735; Expiration Date: 31Jul2021), 1st dose via an unspecified route of administration, administered in Arm Left on 01May2021 at age of 36 years old as a single dose for COVID-19 immunisation. Medical history included celiac disease and gastroparesis. The patient's concomitant medications were not reported. The patient experienced open-angle glaucoma, uveitis, granulomatous anterior uveitis, uveitic ocular hypertension, all on 16May2021, now inflammation that is causing blindness, eye irritation, inflammation, all on an unspecified date. The patient underwent lab tests and procedures which included weight: 73.48 kg, height: 145cm, both on an unknown date. Therapeutic measures were taken as a result of all events. The outcome of the events was not recovered. Clinical course: consumer stated, "I was calling to report a possible side effect I do not see to do it online so I decided to call in." Consumer stated, "I had started to having a eye irritation that has turned into glaucoma that they are thinking had a now inflammation that is causing blindness." Consumer informed about Pfizer medical information department. Consumer stated, "Expiration July 31, 2021." Consumer stated, "Its started on Sunday ( Later confirmed May 16 2021)." Site of vaccination: consumer stated," Left arm." Other medication for medical conditions: consumer stated, "No , nothing Its all diet , its diet regulation." Lab Test: consumer  stated, "No, everything comes negative." Still experiencing the events:  consumer  stated, "Yes, its same." Outcome of events: consumer stated," Same." Treatment in response to events:  Consumer stated,  Valacyclovir, Cyclopentolate, Brimonidine, Acetazolamide, Prednisolone." There had no known allergies. The patient was not pregnancy at time of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received any other medications within 2 weeks of vaccination. The adverse events (open-angle glaucoma, uveitis, granulomatous anterior uveitis, uveitic ocular hypertension) resulted in following: doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The treatment for the adverse events was included medications and eye drops. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Pt recvd vax 13OCT93 & was seen again on 20OCT93 w/lt sided facial palsy whicch had devel subsequent to the vax;